NuVasive® ACP System Study

Inclusion Criteria

• •1. Patients who are ≥18 years of age at the time of consent
• •2. Have planned anterior cervical (C2 to C7) spine surgery using the NuVasive ACP System in conjunction with a NuVasive interbody implant or vertebral body replacement device (VBR), or a structural bone allograft spacer, for treatment of any of the following conditions:
• •1. degenerative disc disease, as defined by neck pain of discogenic origin with degeneration of the disc confirmed by patient history and radiographic studies
• •2. trauma (including fractures)
• •3. tumors involving the cervical spine
• •4. cervical spinal deformity (kyphosis, lordosis, or scoliosis)
• •5. failed previous cervical fusion(s) (e.g., pseudoarthrosis)
• •6. cervical spondylolisthesis
• •7. cervical spinal stenosis
• •3. Able to undergo surgery based on physical exam, medical history, and surgeon judgment
• •4. Understands the conditions of enrollment and is willing to sign an informed consent form to participate in the study